​

Amedisys (AMED) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

AMED Stock Forecast

Amedisys (AMED) stock forecast, based on 25 Wall Street analysts, predicts a 12-month average price target of $143.38, with a high of $190.00 and a low of $85.00. This represents a 56.00% increase from the last price of $91.91.

$50 $80 $110 $140 $170 $200 High: $190 Avg: $143.38 Low: $85 Last Closed Price: $91.91

AMED Stock Rating

Amedisys stock's rating consensus is Hold, based on 25 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 8 Buy (32.00%), 16 Hold (64.00%), 1 Sell (4.00%), and 0 Strong Sell (0.00%).

Hold
Total 25 1 16 8 Strong Sell Sell Hold Buy Strong Buy

AMED Price Target Upside V Benchmarks

TypeNameUpside
StockAmedisys56.00%
SectorHealthcare Stocks 35.25%
IndustryMedical Care Facilities Stocks23.83%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$91.91$91.91$91.91
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 251-101-12
Mar, 251-91-11
Feb, 251-9--10
Jan, 251-81-10
Dec, 241-81-10
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Mar 25, 2024Frank MorganRBC Capital$100.00$92.168.51%8.80%
Jul 06, 2023Brian TanquilutJefferies$90.80$91.28-0.53%-1.21%
Jan 05, 2023Leerink Partners$85.00$86.00-1.16%-7.52%
Nov 11, 2022Stephens$106.00$91.7815.49%15.33%
Jul 26, 2022David MacDonaldTruist Financial$150.00$128.1817.02%63.20%
Jul 03, 2022Justin BowersDeutsche Bank$175.00$110.8257.91%90.40%
Apr 29, 2022Credit Suisse$182.00$131.1338.79%98.02%
Apr 29, 2022Raymond James$180.00$128.4140.18%95.84%
Apr 29, 2022Leerink Partners$131.00$131.89-0.67%42.53%
Feb 25, 2022Matthew BorschBMO Capital$190.00$159.9018.82%106.72%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jul 29, 2024Deutsche BankBuyHolddowngrade
Jul 01, 2024William BlairMarket Performdowngrade
Sep 14, 2023Cantor FitzgeraldNeutralNeutralhold
Jan 05, 2023SVB LeerinkMarket PerformMarket Performhold
Nov 11, 2022StephensEqual-WeightEqual-Weighthold
Oct 27, 2022Raymond JamesOutperformMarket Performdowngrade
Jul 03, 2022Deutsche BankBuyBuyhold
Jun 21, 2022StephensEqual-WeightEqual-Weighthold
Apr 29, 2022Credit SuisseOutperformOutperformhold
Apr 29, 2022Raymond JamesOutperformOutperformhold

Financial Forecast

EPS Forecast

$-1 $0 $1 $2 $3 $4 $5 $6 $7 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$5.64$6.41$3.65$-0.30$4.10---
Avg Forecast$5.94$5.93$4.82$4.38$4.39$4.89$5.19$5.25
High Forecast$6.08$6.07$5.17$4.57$4.46$5.30$5.97$5.37
Low Forecast$5.85$5.84$4.68$4.27$4.36$4.58$4.41$5.17
Surprise %-5.05%8.09%-24.27%-106.85%-6.61%---

Revenue Forecast

$2B $2B $2B $3B $3B $3B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$2.07B$2.21B$2.22B$2.24B$2.35B---
Avg Forecast$2.07B$2.21B$2.23B$2.23B$2.35B$2.47B$2.62B$2.76B
High Forecast$2.11B$2.25B$2.35B$2.24B$2.39B$2.51B$2.62B$2.81B
Low Forecast$2.05B$2.18B$2.18B$2.22B$2.34B$2.44B$2.62B$2.73B
Surprise %-0.13%0.40%-0.24%0.24%0.01%---

Net Income Forecast

$-50M $10M $70M $130M $190M $250M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$183.61M$209.07M$118.61M$-9.75M$134.27M---
Avg Forecast$164.42M$197.17M$133.14M$-9.75M$143.77M$156.15M$156.12M$171.73M
High Forecast$197.30M$236.60M$159.77M$-7.80M$145.54M$172.66M$194.60M$174.94M
Low Forecast$131.53M$157.73M$106.51M$-11.70M$141.99M$149.42M$143.77M$168.51M
Surprise %11.67%6.04%-10.91%--6.61%---

AMED Forecast FAQ

Is Amedisys stock a buy?

Amedisys stock has a consensus rating of Hold, based on 25 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 8 Buy, 16 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Amedisys is a neutral investment for most analysts.

What is Amedisys's price target?

Amedisys's price target, set by 25 Wall Street analysts, averages $143.38 over the next 12 months. The price target range spans from $85 at the low end to $190 at the high end, suggesting a potential 56.00% change from the previous closing price of $91.91.

How does Amedisys stock forecast compare to its benchmarks?

Amedisys's stock forecast shows a 56.00% upside, outperforming the average forecast for the healthcare stocks sector (35.25%) and outperforming the medical care facilities stocks industry (23.83%).

What is the breakdown of analyst ratings for Amedisys over the past three months?

  • April 2025: 8.33% Strong Buy, 0% Buy, 83.33% Hold, 8.33% Sell, 0% Strong Sell.
  • March 2025: 9.09% Strong Buy, 0% Buy, 81.82% Hold, 9.09% Sell, 0% Strong Sell.
  • February 2025: 10.00% Strong Buy, 0% Buy, 90.00% Hold, 0% Sell, 0% Strong Sell.

What is Amedisys’s EPS forecast?

Amedisys's average annual EPS forecast for its fiscal year ending in December 2025 is $4.89, marking a 19.27% increase from the reported $4.1 in 2024. Estimates for the following years are $5.19 in 2026, and $5.25 in 2027.

What is Amedisys’s revenue forecast?

Amedisys's average annual revenue forecast for its fiscal year ending in December 2025 is $2.47B, reflecting a 5.16% increase from the reported $2.35B in 2024. The forecast for 2026 is $2.62B, and $2.76B for 2027.

What is Amedisys’s net income forecast?

Amedisys's net income forecast for the fiscal year ending in December 2025 stands at $156.15M, representing an 16.30% increase from the reported $134.27M in 2024. Projections indicate $156.12M in 2026, and $171.73M in 2027.